Research from the SURPASS and SURMOUNT clinical trial programs has consistently shown this dual mechanism translates into superior clinical outcomes across nearly every measured endpoint
For semaglutide, the relevant secondary patents include: Formulation patents covering the specific inactive ingredients, pH buffers, and stabilizers that keep semaglutide stable in solution (US 9,714,283, expires 2033) Method-of-use patents covering specific dosing schedules and titration protocols (US 10,195,214, expires 2032) Delivery device patents for the pen injector mechanism used in Ozempic and Wegovy (separate patent family, expires 2029-2031) Oral formulation patents for the SNAC (salcaprozate sodium) absorption enhancer used in Rybelsus tablets (US 9,931,349, expires 2032) The expiration date that matters to you depends on which formulation you care about
When you buy from the website, you get the assurance of 100% authentic and genuine products
Its well-suited for those with sensitive stomachs or mild hydration needs
The FDA has acknowledged that litigation challenging these shortage determinations is ongoing